Zdrowie i gospodarka · 09/04/2014
FDA Withdraws Approval of Bupropion Hydrochloride Extended-Release Tablets
The Food and Drug Administration has withdrawn approval of Watson Laboratories' Bupropion Hydrochloride Extended-Release Tablets, 300 milligrams, following a voluntary request from the company.